These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8500324)

  • 21. [Ciliary body changes associate with aldose reductase in galactosemic rats (2)].
    Ikebe H; Terubayashi H; Okamoto S; Matsumoto Y; Tsutsumi M; Ibaraki N; Akagi Y
    Nippon Ganka Gakkai Zasshi; 1992 Jul; 96(7):860-4. PubMed ID: 1502985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effect of orally administered aldose reductase inhibitor SNK-860 on corneal polyol accumulation in galactose-fed rats.
    Kubo E; Nakamura S; Tsuzuki S; Takahashi Y; Akagi Y; Mizuno K; Matsubara A
    Graefes Arch Clin Exp Ophthalmol; 1999 Sep; 237(9):758-62. PubMed ID: 10447652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NIH conference. Aldose reductase and complications of diabetes.
    Cogan DG; Kinoshita JH; Kador PF; Robison G; Datilis MB; Cobo LM; Kupfer C
    Ann Intern Med; 1984 Jul; 101(1):82-91. PubMed ID: 6203454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corneal epithelium in diabetic patients.
    Tsubota K; Chiba K; Shimazaki J
    Cornea; 1991 Mar; 10(2):156-60. PubMed ID: 2019126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical fibronectin ophthalmic solution in the treatment of persistent defects of the corneal epithelium. Chiron Vision Fibronectin Study Group.
    Gordon JF; Johnson P; Musch DC
    Am J Ophthalmol; 1995 Mar; 119(3):281-7. PubMed ID: 7872387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetic complications in the cornea.
    Ljubimov AV
    Vision Res; 2017 Oct; 139():138-152. PubMed ID: 28404521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specular microscopic observation of human corneal epithelial abnormalities.
    Tsubota K; Yamada M; Naoi S
    Ophthalmology; 1991 Feb; 98(2):184-91. PubMed ID: 2008276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aldose reductase inhibition and the phosphorus-31 profile of the intact diabetic rat lens.
    Tsubota K; Yoshida M; Toda T; Ono M; Kajiwara K; Cheng HM
    Ophthalmic Res; 1993; 25(6):393-9. PubMed ID: 8309679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of sorbinil, an aldose reductase inhibitor, on the corneal endothelium in galactosemic dogs.
    Datiles MB; Kador PF; Kashima K; Kinoshita JH; Sinha A
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2201-4. PubMed ID: 2122961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones.
    Bruno G; Costantino L; Curinga C; Maccari R; Monforte F; Nicoló F; Ottanà R; Vigorita MG
    Bioorg Med Chem; 2002 Apr; 10(4):1077-84. PubMed ID: 11836118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corneal endothelial morphology in the rat. Effects of aging, diabetes, and topical aldose reductase inhibitor treatment.
    Meyer LA; Ubels JL; Edelhauser HF
    Invest Ophthalmol Vis Sci; 1988 Jun; 29(6):940-8. PubMed ID: 2967259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistent epithelial defect following penetrating keratoplasty: an adverse effect of diclofenac eyedrops.
    Shimazaki J; Saito H; Yang HY; Toda I; Fujishima H; Tsubota K
    Cornea; 1995 Nov; 14(6):623-7. PubMed ID: 8575187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of 20% Human Serum on Corneal Epithelial Toxicity Induced by Benzalkonium Chloride: In Vitro and Clinical Studies.
    Moon J; Ko JH; Yoon CH; Kim MK; Oh JY
    Cornea; 2018 May; 37(5):617-623. PubMed ID: 29300263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevention of experimental diabetic corneal endotheliopathy with a new aldose reductase inhibitor].
    Terubayashi H; Akagi Y; Takahashi Y; Ikebe H; Miyamoto Y; Ibaraki N; Yokoi N; Tutumi M; Itoi M
    Nippon Ganka Gakkai Zasshi; 1988 Jan; 92(1):151-5. PubMed ID: 3133928
    [No Abstract]   [Full Text] [Related]  

  • 35. [Experimental studies on the corneal damage by the ophthalmic ointment and oil].
    Taniwaki T
    Nippon Ganka Gakkai Zasshi; 1965 Jul; 69(7):809-31; discussion 831. PubMed ID: 5006720
    [No Abstract]   [Full Text] [Related]  

  • 36. Quantitative structure-activity analysis of 5-arylidene-2,4-thiazolidinediones as aldose reductase inhibitors.
    Sambasivarao SV; Soni LK; Gupta AK; Hanumantharao P; Kaskhedikar SG
    Bioorg Med Chem Lett; 2006 Feb; 16(3):512-20. PubMed ID: 16297625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aldose reductase in diabetic complications of the eye.
    Kinoshita JH; Fukushi S; Kador P; Merola LO
    Metabolism; 1979 Apr; 28(4 Suppl 1):462-9. PubMed ID: 45423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro aldose reductase inhibitory activity of some flavonyl-2,4-thiazolidinediones.
    Daş-Evcimen N; Bozdağ-Dündar O; Sarikaya M; Ertan R
    J Enzyme Inhib Med Chem; 2008 Jun; 23(3):297-301. PubMed ID: 18569331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corneal melting associated with use of topical nonsteroidal anti-inflammatory drugs after ocular surgery.
    Lin JC; Rapuano CJ; Laibson PR; Eagle RC; Cohen EJ
    Arch Ophthalmol; 2000 Aug; 118(8):1129-32. PubMed ID: 10922213
    [No Abstract]   [Full Text] [Related]  

  • 40. Aldose reductase and its inhibition in the control of diabetic complications.
    Narayanan S
    Ann Clin Lab Sci; 1993; 23(2):148-58. PubMed ID: 8457142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.